1. Home
  2. FLUX vs KALA Comparison

FLUX vs KALA Comparison

Compare FLUX & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

HOLD

Current Price

$0.55

Market Cap

11.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.53

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLUX
KALA
Founded
N/A
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9M
13.3M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
FLUX
KALA
Price
$0.55
$0.53
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
374.7K
364.1K
Earning Date
05-07-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
67.39
EPS
N/A
N/A
Revenue
$9,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
126.25
N/A
52 Week Low
$0.47
$0.07
52 Week High
$7.55
$19.77

Technical Indicators

Market Signals
Indicator
FLUX
KALA
Relative Strength Index (RSI) 42.40 36.00
Support Level $0.50 $0.51
Resistance Level $0.63 $0.72
Average True Range (ATR) 0.05 0.05
MACD -0.00 0.01
Stochastic Oscillator 15.95 18.67

Price Performance

Historical Comparison
FLUX
KALA

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc. designs, develops, manufactures, and sells a portfolio of lithium-ion energy storage solutions for the electrification of a range of industrial and commercial sectors, which include material handling, airport ground support equipment (GSE), and stationary energy storage. It offers a high-power battery cell management system(BMS). The BMS serves as the brain of the energy storage solution, managing cell balancing, charging, discharging, monitoring, and communication between the pack and the forklift. The company's product portfolio includes Battery Technology and Energy Management solutions.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: